Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Top 3 Health Care Stocks You'll Regret Missing In Q3

Lunai Bioworks Inc. Retains American Defense International

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs